Technical Analysis for APGE - Apogee Therapeutics, Inc.

Grade Last Price % Change Price Change
B 57.35 -5.14% -3.11
APGE closed down 5.14 percent on Tuesday, November 12, 2024, on 70 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Upper Bollinger Band Walk Strength -5.14%
Multiple of Ten Bullish Other -5.14%
Gapped Up Strength -5.14%
Overbought Stochastic Strength -5.14%
Upper Bollinger Band Touch Strength -5.14%
Stochastic Sell Signal Bearish -6.17%
Upper Bollinger Band Walk Strength -6.17%

   Recent Intraday Alerts

Alert Time
Fell Below 10 DMA about 19 hours ago
10 DMA Support about 20 hours ago
Down 5% about 21 hours ago
Down 1 ATR about 21 hours ago
Down 3% about 23 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Immunology Antibodies Monoclonal Antibodies Occupational Safety And Health Chronic Obstructive Pulmonary Disease Atopic Dermatitis Dermatitis Inflammatory Monoclonal Antibody Therapy Copd

Is APGE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 72.29
52 Week Low 16.39
Average Volume 410,161
200-Day Moving Average 49.49
50-Day Moving Average 54.61
20-Day Moving Average 55.55
10-Day Moving Average 57.18
Average True Range 3.11
RSI (14) 53.49
ADX 17.68
+DI 24.61
-DI 19.78
Chandelier Exit (Long, 3 ATRs) 54.18
Chandelier Exit (Short, 3 ATRs) 59.80
Upper Bollinger Bands 61.21
Lower Bollinger Band 49.88
Percent B (%b) 0.66
BandWidth 20.39
MACD Line 1.33
MACD Signal Line 0.88
MACD Histogram 0.4508
Fundamentals Value
Market Cap 2.75 Billion
Num Shares 48 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 64.61
Resistance 3 (R3) 65.04 63.04 63.40
Resistance 2 (R2) 63.04 61.19 62.83 63.00
Resistance 1 (R1) 60.20 60.05 59.20 59.77 62.59
Pivot Point 58.20 58.20 57.71 57.99 58.20
Support 1 (S1) 55.36 56.35 54.36 54.93 52.11
Support 2 (S2) 53.36 55.21 53.15 51.70
Support 3 (S3) 50.52 53.36 51.30
Support 4 (S4) 50.09